Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Codexis ( (CDXS) ) has issued an update.
On January 14, 2025, Codexis, Inc. announced the appointment of Christos Richards to its Board of Directors as a Class II director, with his term extending to the 2027 annual meeting of stockholders. Richards, an experienced executive in the healthcare and life sciences sectors, joins the Nominating and Corporate Governance Committee and the Strategy Committee. His compensation package includes a cash retainer and restricted stock units, emphasizing the company’s strategic focus on enhancing governance and strategy. Richards’ extensive background in executive search and healthcare positions him to contribute significantly to Codexis’ future endeavors.
More about Codexis
YTD Price Performance: -2.60%
Average Trading Volume: 706,882
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $368.6M
Learn more about CDXS stock on TipRanks’ Stock Analysis page.
